Ovarian Adenocarcinoma
CPT-11 and mitomycin C treated ovarian clear cell adenocarcinoma
Published in Women's Health Weekly, August 18th, 2005
"The purpose of this study was to report the results of adjuvant CPT-11 and MMC combination chemotherapy (CPT-M) for OCCA. Between 1996 and 2002, 20 patients with OCCA underwent primary debulking surgery and received 6 treatments of CPT-11 (140 mg/m2) in combination with MMC (7 mg/m2), 2 weeks apart with a space of 3-4 weeks between the 3rd and 4th treatment in adjuvant setting," scientists in Japan reported.
"Overall survival was compared with our historical control treated between 1983...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer Screening
Two-view mammography improves cancer detection - Hypertension
Blood pressure poorly controlled in the elderly, especially women - Osteoporosis
Phase I clinical trial for osteoporosis complete - Reproduction
Ovulatory follicle rupture studied, role of metalloproteinases clarified - Adverse Drug Reaction
Four reported deaths prompt warning about Mifeprex - Alzheimer Disease
Brain changes are more likely to present as dementia in women than in men - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
